Literature DB >> 19914972

Screening and treatment of latent tuberculosis in a cohort of asylum seekers in Norway.

Ingunn Harstad1, Einar Heldal, Sigurd L Steinshamn, Helge Garåsen, Brita A Winje, Geir W Jacobsen.   

Abstract

AIMS: Asylum seekers are screened for tuberculosis at entry to Norway. We aimed to assess follow-up of screening results at different healthcare levels in relation to demographics, screening results and organizational factors, and how this influenced treatment of latent tuberculosis.
METHODS: All asylum seekers >or=18 years with a Mantoux test >or=6 mm or positive x-ray findings who arrived at the National Reception Centre from January 2005 to June 2006, were included. Data were collected from public health authorities in the municipality where the asylum seekers had moved, and from internists in case they had been referred to a specialist. Specialists are responsible for treating latent tuberculosis. Individual subjects were matched with the National Tuberculosis Register to which everybody who had started treatment for latent tuberculosis was reported.
RESULTS: Of 4,643 asylum seekers, 2,237 fulfilled the inclusion criteria. By May 2008, 30 persons had started treatment for latent TB, a median of 17 months (range 3-36) after arrival. A Mantoux test >or=15 mm on arrival was significantly associated with treatment. Demographic factors influenced follow-up in primary healthcare while screening results did not. Referral to specialist was related to screening results. Several specialists were reluctant to diagnose and treat latent tuberculosis and to treat persons without a permanent visa in particular.
CONCLUSIONS: Just 1% of the study group received treatment for latent tuberculosis and with a long time delay. The reason for this may be organizational factors affecting follow-up and referral and specialists not following current guidelines.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19914972     DOI: 10.1177/1403494809353823

Source DB:  PubMed          Journal:  Scand J Public Health        ISSN: 1403-4948            Impact factor:   3.021


  10 in total

1.  Management of latent tuberculous infection in Norway in 2009: a descriptive cross-sectional study.

Authors:  A I M Olsen; H E Andersen; J Aßmus; J A Djupvik; G Gran; K Skaug; O Mørkve
Journal:  Public Health Action       Date:  2013-06-21

2.  The role of entry screening in case finding of tuberculosis among asylum seekers in Norway.

Authors:  Ingunn Harstad; Geir W Jacobsen; Einar Heldal; Brita A Winje; Saeed Vahedi; Anne-Sofie Helvik; Sigurd L Steinshamn; Helge Garåsen
Journal:  BMC Public Health       Date:  2010-11-04       Impact factor: 3.295

3.  Description of the largest cluster of tuberculosis notified in Norway 1997-2011: is the Norwegian tuberculosis control programme serving its purpose for high risk groups?

Authors:  Bernardo R Guzman Herrador; Karin Rønning; Katrine Borgen; Turid Mannsåker; Ulf R Dahle
Journal:  BMC Public Health       Date:  2015-04-11       Impact factor: 3.295

4.  HIV patients with latent tuberculosis living in a low-endemic country do not develop active disease during a 2 year follow-up; a Norwegian prospective multicenter study.

Authors:  Nadine Durema Pullar; Harald Steinum; Johan Nikolai Bruun; Anne Ma Dyrhol-Riise
Journal:  BMC Infect Dis       Date:  2014-12-17       Impact factor: 3.090

Review 5.  Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and meta-analysis.

Authors:  Peter Auguste; Alexander Tsertsvadze; Joshua Pink; Rachel Court; Noel McCarthy; Paul Sutcliffe; Aileen Clarke
Journal:  BMC Infect Dis       Date:  2017-03-09       Impact factor: 3.090

6.  Initiation and completion of treatment for latent tuberculosis infection in migrants globally: a systematic review and meta-analysis.

Authors:  Kieran Rustage; Jessica Lobe; Sally E Hayward; Kristina L Kristensen; Ioana Margineanu; Ymkje Stienstra; Delia Goletti; Dominik Zenner; Teymur Noori; Manish Pareek; Christina Greenaway; Jon S Friedland; Laura B Nellums; Sally Hargreaves
Journal:  Lancet Infect Dis       Date:  2021-08-04       Impact factor: 25.071

7.  Factors associated with latent tuberculosis among asylum seekers in Switzerland: a cross-sectional study in Vaud County.

Authors:  Apostolos Sarivalasis; Jean-Pierre Zellweger; Mohamed Faouzi; Oscar Daher; Charlotte Deslarzes; Patrick Bodenmann
Journal:  BMC Infect Dis       Date:  2012-11-02       Impact factor: 3.090

8.  Collaboration between municipal and specialist public health care in tuberculosis screening in Norway.

Authors:  Ingunn Harstad; Anne H Henriksen; Eli Sagvik
Journal:  BMC Health Serv Res       Date:  2014-05-27       Impact factor: 2.655

Review 9.  Review of infectious diseases in refugees and asylum seekers-current status and going forward.

Authors:  Andreas Halgreen Eiset; Christian Wejse
Journal:  Public Health Rev       Date:  2017-09-08

10.  Treatment completion for latent tuberculosis infection in Norway: a prospective cohort study.

Authors:  Yvette Louise Schein; Tesfaye Madebo; Hilde Elise Andersen; Trude Margrete Arnesen; Anne Ma Dyrhol-Riise; Hallgeir Tveiten; Richard A White; Brita Askeland Winje
Journal:  BMC Infect Dis       Date:  2018-11-19       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.